Hongene is thrilled to announce our participation in TIDES Asia 2025. The exclusive Asia-Pacific gathering where leaders in oligonucleotide, peptide, mRNA, and genome editing converge to share cutting-edge strategies across discovery, development, and CMC - advancing next-generation therapeutics through collaborative innovation.
Welcome to visit our booth #4. Let's discuss how Hongene's high-quality nucleic acid products and end-to-end RNA medicines solution can help make your project successful.